stonks4u
Log inSign up free
MDRX logo

MDRX Veradigm Inc.

Other OTC · Medical - Healthcare Information Services · Healthcare

$4.90
-0.10 (-2.00%)

Veradigm Inc. is a global healthcare technology enterprise that delivers cutting-edge information technology platforms to a diverse client base, including healthcare providers, health plans (payers), and biopharmaceutical companies, operating across the United States and various international markets. For healthcare providers, the company offers a suite of integrated solutions designed to optimize…

Market Cap: $832.17Mveradigm.com

Price

No data yet.

Signal Score (90d)

100
100
Aug 17Aug 17

Quote

Day Range
$4.55 – $4.90
52-Week Range
$3.00 – $6.00
Volume
$2.1K
Market Cap
$832.17M
50-Day Avg
$4.78
200-Day Avg
$4.67
Prev Close
$5.00
Open
$4.55

Valuation & Ratios

P/E Ratio
-26.33
EPS
$-0.67
P/B Ratio
2.23
P/S Ratio
3.87
Debt/Equity
0.22
Current Ratio
2.95
Dividend Yield
+0.0%
Gross Margin
+52.5%

Returns & Efficiency

Return on Equity
-8.5%
Return on Assets
-5.7%
FCF Yield
+3.7%
EV/EBITDA
35.03

Revenue & Net Income (Annual)

Fiscal YearRevenueNet IncomeEPS
2022$588.02M$-86.46M$-0.67
2021$577.43M$134.44M$1.03
2020$1.50B$700.41M$4.37
2019$1.63B$-182.18M$-1.10
2018$1.75B$363.74M$2.07

Social Signal Score

50
5d
51
1 mentions
—
30d
50
1 mentions
—
60d
50
1 mentions
—
90d
50
1 mentions
—
news: 1

Earnings

Mon, Aug 17(date passed)

Consensus estimate $0.09 per share

4of 6 quarters beat consensus

Typical surprise +0.0% (median, so one quarter with a near-zero estimate can't distort it)

  • Tue, May 26$0.22 vs $0.17beat
  • Fri, Feb 27$0.09 vs $0.07beat
  • Fri, Nov 7$0.05 vs $0.05beat
  • Fri, Aug 8$0.07 vs $0.07beat
  • Tue, Mar 18$0.06 vs $0.07miss
  • Fri, Feb 28$0.19 vs $0.31miss

Estimates and results for MDRX via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.

Insider trading

Open-market buys and sells by MDRX officers and directors.

Bought
$66.0m

6 trades

Sold
—

0 trades

  • Stonehill Capital Management Llcbought
    10 percent owner·2,398,725 @ $6.00·$14.4m·Mar 1, 2024·filing
  • Stonehill Capital Management Llcbought
    10 percent owner·1,599,150 @ $6.00·$9.6m·Mar 1, 2024·filing
  • Stonehill Capital Management Llcbought
    10 percent owner·278,250 @ $6.09·$1.7m·Feb 29, 2024·filing
  • Stonehill Capital Management Llcbought
    10 percent owner·246,750 @ $6.09·$1.5m·Feb 29, 2024·filing
  • Stonehill Capital Management Llcbought
    10 percent owner·3,021,000 @ $6.81·$20.6m·Feb 28, 2024·filing
  • Stonehill Capital Management Llcbought
    10 percent owner·2,679,000 @ $6.81·$18.2m·Feb 28, 2024·filing

94 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.

Valuation

MDRXhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.

Mentions (1)

  • Newsbusinesswire.com·6h ago·Neutral

    Veradigm to Participate in Two Upcoming Investor Conferences CHICAGO--(BUSINESS WIRE)--Veradigm® (OTCMKTS: MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, announced today that management will be participating in the following investor conferences in September. 2026 Jefferies Healthcare Services and Technology Conference (Nashville, September 15, 2026) Don Trigg, Chief Executive Officer, and Christian Greyenbuhl, Chief Financial Officer, will hold one-…

    View source ↗